Your browser doesn't support javascript.
loading
Molecular MRD status and outcome after transplantation in NPM1-mutated AML.
Dillon, Richard; Hills, Robert; Freeman, Sylvie; Potter, Nicola; Jovanovic, Jelena; Ivey, Adam; Kanda, Anju Shankar; Runglall, Manohursingh; Foot, Nicola; Valganon, Mikel; Khwaja, Asim; Cavenagh, Jamie; Smith, Matthew; Ommen, Hans Beier; Overgaard, Ulrik Malthe; Dennis, Mike; Knapper, Steven; Kaur, Harpreet; Taussig, David; Mehta, Priyanka; Raj, Kavita; Novitzky-Basso, Igor; Nikolousis, Emmanouil; Danby, Robert; Krishnamurthy, Pramila; Hill, Kate; Finnegan, Damian; Alimam, Samah; Hurst, Erin; Johnson, Peter; Khan, Anjum; Salim, Rahuman; Craddock, Charles; Spearing, Ruth; Gilkes, Amanda; Gale, Rosemary; Burnett, Alan; Russell, Nigel H; Grimwade, David.
Affiliation
  • Dillon R; Department of Medical and Molecular Genetics, King's College, London, United Kingdom.
  • Hills R; Cancer Genetics Service, Viapath, Guy's Hospital, London, United Kingdom.
  • Freeman S; Department of Haematology, Guy's Hospital, London, United Kingdom.
  • Potter N; Nuffield Department of Population Health, University of Oxford, United Kingdom.
  • Jovanovic J; Institute of Immunology and Immunotherapy, University of Birmingham, United Kingdom.
  • Ivey A; Department of Medical and Molecular Genetics, King's College, London, United Kingdom.
  • Kanda AS; Cancer Genetics Service, Viapath, Guy's Hospital, London, United Kingdom.
  • Runglall M; Department of Medical and Molecular Genetics, King's College, London, United Kingdom.
  • Foot N; Department of Medical and Molecular Genetics, King's College, London, United Kingdom.
  • Valganon M; Department of Medical and Molecular Genetics, King's College, London, United Kingdom.
  • Khwaja A; Department of Medical and Molecular Genetics, King's College, London, United Kingdom.
  • Cavenagh J; Cancer Genetics Service, Viapath, Guy's Hospital, London, United Kingdom.
  • Smith M; Cancer Genetics Service, Viapath, Guy's Hospital, London, United Kingdom.
  • Ommen HB; Department of Haematology, University College, London, United Kingdom.
  • Overgaard UM; Bart's Hospital, London, United Kingdom.
  • Dennis M; Bart's Hospital, London, United Kingdom.
  • Knapper S; University Hospital, Aarhus, Denmark.
  • Kaur H; Rigshospitalet, Copenhagen, Denmark.
  • Taussig D; Christie Hospital, Manchester, United Kingdom.
  • Mehta P; Department of Haematology, Cardiff University, Cardiff, United Kingdom.
  • Raj K; Royal Hallamshire Hospital, Sheffield, United Kingdom.
  • Novitzky-Basso I; Royal Marsden Hospital, Sutton, United Kingdom.
  • Nikolousis E; Bristol Haematology and Oncology Centre, Bristol, United Kingdom.
  • Danby R; Department of Haematology, Guy's Hospital, London, United Kingdom.
  • Krishnamurthy P; Beatson Cancer Centre, Glasgow, United Kingdom.
  • Hill K; Heartlands Hospital, Birmingham, United Kingdom.
  • Finnegan D; Churchill Hospital, Oxford, United Kingdom.
  • Alimam S; Addenbrooke's Hospital, Cambridge, United Kingdom.
  • Hurst E; University Hospital, Southampton, United Kingdom.
  • Johnson P; Belfast City Hospital, Belfast, United Kingdom.
  • Khan A; Department of Medical and Molecular Genetics, King's College, London, United Kingdom.
  • Salim R; Department of Haematology, Guy's Hospital, London, United Kingdom.
  • Craddock C; Royal Victoria Infirmary, Newcastle, United Kingdom.
  • Spearing R; Western General Hospital, Edinburgh, United Kingdom.
  • Gilkes A; St James' Hospital, Leeds, United Kingdom.
  • Gale R; Clatterbridge Cancer Centre, Liverpool, United Kingdom.
  • Burnett A; Queen Elizabeth Hospital, Birmingham, United Kingdom.
  • Russell NH; Christchurch Hospital, Christchurch, New Zealand.
  • Grimwade D; Department of Haematology, Cardiff University, Cardiff, United Kingdom.
Blood ; 135(9): 680-688, 2020 02 27.
Article in En | MEDLINE | ID: mdl-31932839
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nuclear Proteins / Leukemia, Myeloid, Acute / Neoplasm, Residual Type of study: Diagnostic_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2020 Document type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nuclear Proteins / Leukemia, Myeloid, Acute / Neoplasm, Residual Type of study: Diagnostic_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2020 Document type: Article Affiliation country: United kingdom